RayMed develops RayVision™, a radiopharmaceutical treatment planning software that utilizes PET-SPECT/CT imaging and artificial intelligence to calculate absorbed doses and assess biodistribution in patients. This technology enables medical professionals to create personalized treatment plans, significantly improving accuracy and reducing calculation time from weeks to minutes.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for treatment planning in radiopharmaceutical therapy, particularly Monte Carlo simulations, are time-consuming, often taking weeks to calculate radiation dose distributions. This delay hinders the ability of medical professionals to rapidly personalize treatment plans and optimize therapeutic efficacy for cancer patients.
Solution
RayMed's RayVision™ is a radiopharmaceutical treatment planning software that leverages PET-SPECT/CT imaging and artificial intelligence to provide rapid and accurate absorbed dose calculation and biodistribution assessment. By integrating patient-specific image data with AI-driven micro-dosimetry calculations, RayVision™ enables clinicians to visualize predicted biodistribution and assess precise absorbed doses within minutes. This accelerated workflow facilitates the creation of tailored treatment plans, optimizing therapeutic efficacy while enhancing cost efficiency. The software integrates with hospital PACS systems to streamline data input and visualization.
Target Audience
The primary target audience includes radiation oncologists, nuclear medicine physicians, and medical physicists involved in radiopharmaceutical therapy treatment planning.
Features
- AI-powered dose calculation engine that reduces calculation time from weeks to minutes
- Integration with hospital PACS for direct access to patient image data (PET-SPECT/CT)
- Visualization of predicted radiopharmaceutical biodistribution in 3D
- Personalized treatment planning based on individual patient dosimetry
- Micro-dosimetry calculations for precise dose assessment with RBE (Relative Biological Effectiveness) for alpha and beta emitters
- Medical diagnostic support software with graphic, image, and video processing capabilities